BOC Sciences - Products
London
BOC Sciences provides various research (bio)chemicals: inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities, metabolites, APIs, natural compounds, ADCs, and chiral compounds.
| Product | Description | |
|---|---|---|
| Tinosporol A | Tinosporol A, a constituent of Tinospora cordifolia, boasts anti-inflammatory and anticancer properties. Its effectiveness at thwarting the growth of cancer cells - leukemic and colon alike - is scientifically documented. Moreover, Tinosporol A has shown inhibitory capacities in the production of inflammatory cytokines, contributing to its potential as an anti-inflammatory agent. Group: Pharmaceutical. CAS No. 2244777-12-4. Pack Sizes: 5 mg. Product ID: NP1388. Molecular formula: Custom synthesis is available. Send your inquiries for more information. |  London |
| Tinosporoside A | Tinosporoside A is a natural compound found in Tinospora cordifolia. It exhibits potential in studying various diseases such as cancer, diabetes and liver disorders. Group: Pharmaceutical. CAS No. 2244777-15-7. Pack Sizes: 5 mg. Product ID: NP1386. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Tioconazole Impurities | Tioconazole Impurities are critical in the analysis and quality control of tioconazole formulations. These impurities play a role in ensuring the efficacy and safety of tioconazole, an antifungal agent used to treat conditions like vaginal yeast infections and other fungal skin infections. Identification aids in optimizing therapeutic outcomes. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Tioconazole Related Compound A | One impurity of Tioconazole, which could be used as an antifungal agent and exhibit activities against Candida glabrata mutant strains. Group: Pharmaceutical. CAS No. 61709-33-9. Pack Sizes: 1 g. Product ID: B1370-484193. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Tiopronin Impurities | Tiopronin Impurities, serving as indispensable reference benchmarks, are crucial within pharmaceutical research. They underpin the assurance of Tiopronin formulation quality and safety by elucidating drug stability, degradation pathways, and toxicity profiles. These insights are vital for therapeutic strategies in cystinuria, simultaneously advancing diverse drug-development initiatives. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Tiotropium bromide hydrate | Tiotropium Bromide hydrate is a monohydrate of tiotropium bromide (Spiriva; Tiova; BA 679BR; tiopropium) that is an anticholinergic and bronchodilator and a muscarinic receptor antagonist. Group: Pharmaceutical. CAS No. 139404-48-1. Pack Sizes: 1 g. Product ID: B0084-463409. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Tipelukast Impurities | Tipelukast Impurities play a critical role in ensuring the quality, safety, and efficacy of pharmaceutical formulations involving the leukotriene receptor antagonist, Tipelukast. These impurities are particularly important for assessing potential side effects and improving therapeutic interventions in conditions such as asthma and allergic rhinitis. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Tipiracil HCl | Tipiralacil, also known as TPI, is a thymidine phosphorylase inhibitor (TPI). Tipiracil is one of the active components in TAS-102, which is an anticancer drug candidate currently in clinical trials. TAS-102 consists of the cytotoxin Trifluridine and the thymidine phosphorylase inhibitor (TPI) tipiracil. Trifluridine is incorporated into DNA during DNA synthesis and inhibits tumor cell growth. Tipiracil protects trifluridine from being broken down when taken orally. Group: Pharmaceutical. CAS No. 183204-72-0. Pack Sizes: 500 mg. Product ID: B0084-424412. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Tipiracil Impurities | Tipiracil Impurities are crucial in the biomedical industry for analytical and quality control procedures during the production of tipiracil, a chemotherapeutic agent. Tipiracil is used in combination with trifluridine to treat metastatic colorectal cancer, enhancing understanding of drug stability, efficacy, and safety testing. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Tiplaxtinin | Tiplaxtinin is a novel plasminogen activator inhibitor-1 (PAI-1) inhibitor. It is an orally active prothrombolytic drug that inhibits PAI-1 and accelerates fibrinolysis while maintaining normal coagulation in a model of coronary occlusion. It exerts antithrombotic efficacy in rat models of arterial and venous vascular injury without effecting platelet aggregation. Group: Pharmaceutical. CAS No. 393105-53-8. Pack Sizes: 100 mg. Product ID: B2693-115471. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Tipranavir Impurities | Tipranavir Impurities are crucial in the pharmaceutical industry for quality control during the production of Tipranavir, an antiretroviral drug used to treat HIV-1 infections. These impurities help ensure the drug's safety, efficacy, and stability by providing insight into the degradation pathways and potential contaminants. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Tirapazamine | Tirapazamine is a benzotriazine di-N-oxide with potential antineoplastic activity. Tirapazamine is selectively activated by multiple reductases to form free radicals in hypoxic cells, thereby inducing single-and double-strand breaks in DNA, base damage, and cell death. This agent also sensitizes hypoxic cells to ionizing radiation and inhibits the repair of radiation-induced DNA strand breaks via inhibition of topoisomerase II. Check for active clinical trials or closed clinical trials using this agent. Group: Pharmaceutical. CAS No. 27314-97-2. Pack Sizes: 1 g. Product ID: B2693-350792. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Tirofiban Hydrochloride Monohydrate | Tirofiban is a specific nonpeptide platelet fibrinogen receptor (GPIIb/IIIa) antagonist. Tirofiban is an antithrombotic used in the treatment of unstable angina. Uses: The treatment of unstable angina. Group: Pharmaceutical. CAS No. 150915-40-5. Pack Sizes: 100 mg. Product ID: B0084-084608. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Tirofiban Impurities | Tirofiban Impurities play a critical role in the intricate development and stringent quality assurance of antiplatelet pharmaceuticals, especially targeting thromboembolic pathologies. Their analysis is vital for validating the potency and safety of tirofiban, a glycoprotein IIb/IIIa antagonist employed to avert thrombosis during acute coronary syndrome and percutaneous cardiac interventions. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Tirofiban Impurity C | One of the impurities of Tirofiban, which has been found to be a glycoprotein IIb/IIIa inhibitor and could be used as an antiplatelet agent. Group: Pharmaceutical. CAS No. 149490-61-9. Pack Sizes: 1 g. Product ID: B1887-084513. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Tiropramide Impurities | Tiropramide Impurities, primarily used in analytical settings, play a critical role in ensuring the purity and efficacy of Tiropramide, a drug targeting smooth muscle spasms in the gastrointestinal tract. These impurities assist in monitoring and controlling the quality of the pharmaceutical formulations for optimal therapeutic outcomes. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Tirzepatide | Tirzepatide is a dual GIP and GLP-1 receptor agonist and a drug candidate for the treatment of type 2 diabetes. Uses: treating type 2 diabetes is one of the main conditions where tirzepatide shows promise. millions of people worldwide suffer with this chronic illness, which is characterized by poor glucose metabolism and insulin resistance. targeting several receptors, such as the glucose-dependent insulinotropic polypeptide (gip) and glucagon-like peptide-1 (glp-1) receptors, is part of tirzepatide's distinct. Group: Pharmaceutical. CAS No. 2023788-19-2. Pack Sizes: 5 mg. Product ID: BAT-006246. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Tirzepatide Impurities | Tirzepatide impurities are critical for ensuring the purity and efficacy of Tirzepatide, a novel drug used for treating type 2 diabetes and obesity. By identifying and quantifying these impurities, researchers can enhance drug safety and stability, facilitating improved therapeutic outcomes and compliance with pharmaceutical regulations. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Titanium diboride | Titanium diboride. Group: Pharmaceutical. CAS No. 12045-63-5. Pack Sizes: 1 kg. Product ID: B1370-055640. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Tivozanib | Tivozanib is an orally bioavailable inhibitor of vascular endothelial growth factor receptors (VEGFRs) 1, 2 and 3 with potential antiangiogenic and antineoplastic activities. Tivozanib binds to and inhibits VEGFRs 1, 2 and 3, which may result in the inhibition of endothelial cell migration and proliferation, inhibition of tumor angiogenesis and tumor cell death. VEGFR tyrosine kinases, frequently overexpressed by a variety of tumor cell types, play a key role in angiogenesis. Check for active clinical trials or closed clinical trials using this agent. Group: Pharmaceutical. CAS No. 475108-18-0. Pack Sizes: 50 mg. Product ID: B2693-413727. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Tixocortol Pivalate | Tixocortol Pivalate is a corticosteroid showing topical anti-inflammatory properties. It is marketed under the brand name Pivalone. Group: Pharmaceutical. CAS No. 55560-96-8. Pack Sizes: 100 mg. Product ID: B0046-413729. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Tizanidine hydrochloride | Tizanidine is an α2-adrenergic receptor agonist and inhibits neurotransmitter release from CNS noradrenergic neurons. Group: Pharmaceutical. CAS No. 64461-82-1. Pack Sizes: 25 g. Product ID: B0084-074328. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Tizanidine Impurities | Tizanidine Impurities hold paramount importance as analytical benchmarks within the pharmaceutical realm, facilitating rigorous quality control and stability evaluations of Tizanidine, a muscle relaxant prescribed for spasticity in multiple sclerosis, spinal trauma, and cerebral palsy. These impurities underscore the imperative of drug safety and efficacy during both formulation and production phases. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Tizoxanide | Tizoxanide is the active metabolite of nitazoxanide, an anti-infective that has been approved for the treatment of diarrhea caused by Giardia lamblia or Crytosporidium parvum. Tizoxanide is active against anaerobic bacteria, protozoan parasites, and viruses. It reduces the growth of the disease-causing parasites, L. mexicana and T. cruzi, in vitro (IC50s = 6.2 and 17.5 μM, respectively), inhibits influenza A replication (EC50s = 0.3-1 μM)3, and inhibits hepatitis B and hepatitis C virus replication (EC50s both = 0.15 μM). Uses: Anti-infective agents. Group: Pharmaceutical. CAS No. 173903-47-4. Pack Sizes: 100 mg. Product ID: B0084-264133. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Tizoxanide-[d4] | Tizoxanide-[d4] is the labelled analogue of Tizoxanide. Tizoxanide is the active metabolite of nitazoxanide, an anti-infective that has been approved for the treatment of diarrhea caused by Giardia lamblia or Crytosporidium parvum. Tizoxanide is active against anaerobic bacteria, protozoan parasites, and viruses. Group: Pharmaceutical. CAS No. 1246817-56-0. Pack Sizes: 10 mg. Product ID: BLP-012626. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| TLR7/8 agonist 1 | TLR7/8 agonist 1 is a dual agonist of toll-like receptor 7 (TLR7) and TLR8. It exhibits prominent immunostimulatory activities. Group: Pharmaceutical. CAS No. 1258457-59-8. Pack Sizes: 100 mg. Product ID: B2693-009945. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| TLR7/8 agonist 1 dihydrochloride | TLR7/8 agonist 1 is a dual agonist of toll-like receptor 7 (TLR7) and TLR8. It exhibits prominent immunostimulatory activities. Group: Pharmaceutical. CAS No. 1620278-72-9. Pack Sizes: 100 mg. Product ID: B2693-009887. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| TM-5275 sodium salt | TM-5275 sodium salt is an orally bioavailable, potent and selective plasminogen activator inhibitor-1 (PAI-1). It delivers antithrombotic benefits devoid of bleeding effect in nonhuman primates. Uses: Tm-5275 sodium salt delivers antithrombotic benefits devoid of bleeding effect in nonhuman primates. Group: Pharmaceutical. CAS No. 1103926-82-4. Pack Sizes: 100 mg. Product ID: B2693-475064. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| TMC-58B | Aurantiamide, a natural alkaloid found in the herbs of Walsura yunnanensis, is used as significant anti-inflammatory and antinociceptive. it can serve as the natural compound for inhibiting cysteine proteinases, in particular, cathepsin L (3.4.22.15) and B (3.4.22.1) with IC50 of 12 microM and 49 microM, respectively. It may suppress the growth of malignant gliomas by blocking autophagic flux. Uses: Anti-neuroinflammatory; anti-inflammatory; antinociceptive. Group: Pharmaceutical. CAS No. 58115-31-4. Pack Sizes: 1 mg. Product ID: NP0417. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| TMP269 | TMP269 is a highly potent, selective and cell-permeable class IIa HDAC inhibitor with IC50 values of 126 nM, 80 nM, 36 nM and 19 nM for HDAC4, HDAC5, HDAC7 and HDAC9 respectively. Group: Pharmaceutical. CAS No. 1314890-29-3. Pack Sizes: 25 mg. Product ID: B0084-462603. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| TNF-α (10-36), human | TNF-α (10-36), human is a peptide of human TNF-&alpha. Group: Pharmaceutical. CAS No. 144796-70-3. Pack Sizes: 5 mg. Product ID: BAT-006244. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| TNF-α (46-65), human | TNF-α (46-65), human is a compound accomplishing its efficacy by specifically targeting a fragment of Tumor Necrosis Factor-alpha (TNF-α), finding purpose in the studyof diverse conditions, encompassing rheumatoid arthritis, psoriasis, Crohn's disease and ulcerative colitis. Group: Pharmaceutical. CAS No. 144796-72-5. Pack Sizes: 5 mg. Product ID: BAT-006197. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| TNKS656 | TNKS656, also known as NVP-TNKS656, is a potent and orally active Tankyrase Inhibitor. With an enthalpy-driven thermodynamic signature of binding, highly favorable physicochemical properties, and high lipophilic efficiency, TNKS656 is well suited for further in vivo validation studies. Group: Pharmaceutical. CAS No. 1419949-20-4. Pack Sizes: 5 mg. Product ID: B2693-462604. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| TNO155 | TNO155 is an inhibitor of protein tyrosine phosphatase (PTP) non-receptor type 11 (SHP2; src homology region 2 domain phosphatase; PTPN11), with potential antineoplastic activity. Group: Pharmaceutical. CAS No. 1801765-04-7. Pack Sizes: 5 mg. Product ID: B2693-008828. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Tobramycin | Tobramycin is an aminoglycoside antibiotic with an IC50 of 9.7 μM. Group: Pharmaceutical. CAS No. 32986-56-4. Pack Sizes: 1 g. Product ID: BBF-04568. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Tobramycin Impurities | Tobramycin impurities are crucial in the biomedical industry for developing and optimizing Tobramycin-based therapies. They serve as reference standards, ensuring quality control in the synthesis of Tobramycin, an aminoglycoside antibiotic used primarily to treat severe bacterial infections like Pseudomonas aeruginosa in cystic fibrosis and other resistant infections. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Tocainide Impurities | Tocainide Impurities constitute a fundamental aspect in the realm of biomedical analytics, essential during the rigorous quality assurance phase of tocainide, an antiarrhythmic agent targeting ventricular arrhythmias. Scrutinizing these impurities guarantees tocainide's therapeutic safety and efficacy, thereby underpinning its clinical application and pharmacological integrity. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Toceranib phosphate | Toceranib phosphate is a kinase inhibitor with both antitumor and antiangiogenic activity through inhibition of KIT, vascular endothelial growth factor receptor 2, and PDGFR&beta. It is a receptor tyrosine kinase inhibitor and is used in the treatment of canine mast cell tumor also called mastocytoma. It may also have an anti-angiogenic effect. Group: Pharmaceutical. CAS No. 874819-74-6. Pack Sizes: 1 g. Product ID: B0084-463666. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Tocofersolan | Vitamin E polyethylene glycol succinate is an esterified vitamin E (tocopherol) derivative primarily used as a solubilizer or emulsifying agent because of its surfactant properties. And it can be used to treat vitamin E deficiency. Group: Pharmaceutical. CAS No. 9002-96-4. Pack Sizes: 100 g. Product ID: B0275-079197. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Tocopherol Impurity 1 | One of the impurities of Vitamin E, which has been found to exhibit antioxidant activity. Group: Pharmaceutical. CAS No. 3808-26-2. Pack Sizes: 5 mg. Product ID: B2694-485238. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Toddalolactone | Toddalolactone usually can be isolated from the roots of Toddalia asiatica Lam. Uses: Anti-inflammatory/analgesic/anti-cancer. Group: Pharmaceutical. CAS No. 483-90-9. Pack Sizes: 20 mg. Product ID: NP1106. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Toddalosin | Toddalosin is a bicoumarin isolated from Toddalia asiatica. Group: Pharmaceutical. CAS No. 137182-37-7. Pack Sizes: 5 mg. Product ID: NP1086. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| TOFA | TOFA is a cell-permeable, potent, reversible, and competitive allosteric inhibitor of acetyl-CoA carboxylase-α (ACCA). It inhibits the fatty acid biosynthesis by blocking the synthesis of malonyl-CoA. Uses: Hypolipidemic agents. Group: Pharmaceutical. CAS No. 54857-86-2. Pack Sizes: 100 mg. Product ID: B0084-374809. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Tofacitinib | Tofacitinib is an orally available JAK3 inhibitor (IC50 = 1 nM), exhibiting 20- and 100-fold less potency against JAK2 and JAK1. Tofacitinib induces G1 cell cycle arrest and inhibits tumor growth in Epstein-Barr virus-associated T and natural killer cell lymphoma cells. It is approved for the treatment of rheumatoid arthritis (RA). Group: Pharmaceutical. CAS No. 477600-75-2. Pack Sizes: 1 g. Product ID: B0084-453466. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Tofacitinib citrate | Tofacitinib (trade name Xeljanz, formerly tasocitinib, CP-690550) is a drug discovered and developed by Pfizer. It is currently approved for the treatment of rheumatoid arthritis (RA) in the United States and is being studied for treatment of psoriasis, inflammatory bowel disease, and other immunological diseases, as well as for the prevention of organ transplant rejection. (source: http://en. wikipedia. org/wiki/Tofacitinib). Uses: Janus kinase inhibitors. Group: Pharmaceutical. CAS No. 540737-29-9. Pack Sizes: 500 mg. Product ID: NP2603. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Tofacitinib Citrate Impurities | Tofacitinib Citrate Impurities, central to quality control in the pharmaceutical sector, are critical in scrutinizing the developmental and stability aspects of Tofacitinib utilized for rheumatoid arthritis and ulcerative colitis treatment. Meticulous examination of these impurities fortifies drug safety and potency, thus ensuring compliance with rigorous regulatory mandates. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Tofacitinib Impurities | Tofacitinib Impurities constitute essential components in the quality assurance and safety evaluation of Tofacitinib, a Janus kinase inhibitor addressing diseases such as rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. They facilitate researchers in guaranteeing drug purity, efficacy, and adherence to regulatory standards, ensuring rigorous pharmaceutical formulations. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Tofacitinib N-Oxide | Tofacitinib N-Oxide is an impurity of Tofacitinib, which is a Janus kinase inhibitor and could be used against rheumatoid arthritis. Group: Pharmaceutical. CAS No. 2028267-73-2. Pack Sizes: 50 mg. Product ID: B2694-006572. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Tofogliflozin hydrate | Tofogliflozin(CSG-452) hydrate is a potent and highly specific sodium/glucose cotransporter 2(SGLT2) inhibitor with Ki values of 2.9, 14.9, and 6.4 nM for human, rat, and mouse SGLT2. Group: Pharmaceutical. CAS No. 1201913-82-7. Pack Sizes: 25 mg. Product ID: B2693-463127. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Tofogliflozin Impurities | Tofogliflozin Impurities play a crucial role in pharmaceutical research, primarily in the quality control and stability assessment of Tofogliflozin formulations. Tofogliflozin, a selective SGLT2 inhibitor, is utilized in managing type 2 diabetes. Monitoring its impurities ensures safety and efficacy in diabetes treatment. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Tolafentrine Impurities | Tolafentrine Impurities, integral to the R&D of phosphodiesterase inhibitors, offer invaluable insights into the stability, safety, and therapeutic efficacy of cardiovascular and respiratory treatments. Their study aids in refining drug formulations, enhancing the efficacy of therapies targeting asthma and chronic obstructive pulmonary disease, ultimately advancing pharmacological innovation. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Tolbutamide Impurities | Tolbutamide Impurities are critical in evaluating the quality and safety of tolbutamide, an essential sulfonylurea drug used to manage type 2 diabetes. These impurities help identify potential side effects and ensure compliance with pharmacopoeial standards during drug manufacturing, ultimately contributing to safer and more effective diabetes treatments. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Tolcapone | Tolcapone functions as a selective peripheral and central COMT inhibitor, exerting no effect on adrenergic, serotonergic, or cholinergic receptors or other enzymes involved in synthesis or catabolism of catecholamines. Group: Pharmaceutical. CAS No. 134308-13-7. Pack Sizes: 250 mg. Product ID: B0084-352400. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Tolcapone Impurities | Tolcapone Impurities, as fundamental chemical derivatives, play an indispensable role in the scrutinization of tolcapone-related pharmaceuticals. Their integration is crucial in Parkinson's disease treatment, guaranteeing formulation purity and efficacy, while providing in-depth analysis of metabolic pathways, thus advancing pharmaceutical development and ensuring therapeutic reliability. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Tolfenpyrad | Tolfenpyrad is used as foliar insecticide for the control of green peach aphids in broccoli. Group: Pharmaceutical. CAS No. 129558-76-5. Pack Sizes: 5 g. Product ID: B0084-056856. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Tolmetin Impurities | Tolmetin Impurities are critical in pharmaceutical analysis and research, utilized for characterizing the purity and stability of tolmetin formulations, a nonsteroidal anti-inflammatory drug. Understanding these impurities aids in evaluating the drug's therapeutic efficacy in treating conditions like arthritis and musculoskeletal disorders. Insights into impurities ensure safe and effective tolmetin usage. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Tolnaftate Impurities | Tolnaftate Impurities are critical in the biomedical industry for quality control and pharmaceutical research. They assist in understanding the purity and efficacy of Tolnaftate, an antifungal drug used to treat conditions like athlete's foot and ringworm. Detecting and characterizing these impurities ensure the safety and effectiveness of antifungal therapies. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Tolperisone Impurities | Tolperisone Impurities, integral in ensuring stringent quality control of Tolperisone, a muscle relaxant essential for managing muscle spasms and rigidity in disorders such as multiple sclerosis and spinal cord injuries. Analyzing these impurities enhances drug efficacy and safety, propelling pharmaceutical formulation progress and therapeutic reliability. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Tolterodine Impurities | Tolterodine Impurities, frequently encountered in pharmaceutical research and drug development, play a critical role in ensuring the purity and efficacy of tolterodine, a drug used for treating overactive bladder. Identifying these impurities is paramount in minimizing adverse reactions and improving therapeutic outcomes for patients suffering from this urological condition. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Tolterodine Tartrate | Tolterodine has a high affinity and specificity for muscarinic receptors in vitro and it exhibits selectivity for the urinary bladder over salivary glands in vivo. Uses: Urological agents. Group: Pharmaceutical. CAS No. 124937-52-6. Pack Sizes: 1 g. Product ID: B0046-464021. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Toltrazuril | Toltrazuril can be used to treat poultry coccidiosis. Group: Pharmaceutical. CAS No. 69004-03-1. Pack Sizes: 5 g. Product ID: NP2641. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Toltrazuril Impurities | Toltrazuril Impurities, integral to the advancement of toltrazuril as an antiprotozoal pharmaceutical, undergo meticulous scrutiny to certify drug efficacy and safety. Primarily targeting coccidiosis, a daunting parasitic ailment impacting livestock and poultry, these impurities play a crucial role in safeguarding and promoting optimal animal health. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Tolvaptan Impurities | Tolvaptan Impurities are critical in the biomedical field for assessing the purity and safety of Tolvaptan, a vasopressin receptor antagonist used to treat hyponatremia and autosomal dominant polycystic kidney disease (ADPKD). Monitoring these impurities ensures the therapeutic efficacy and patient safety of Tolvaptan formulations. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| tolycaine | Tolycaine is an amide local anaesthetic used for dental injection. Group: Pharmaceutical. CAS No. 3686-58-6. Pack Sizes: 1 g. Product ID: B2692-113074. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| TOMATINE | Tomatine is a glycoalkaloid extracted from the fruits of Solanum lycopersicum. Group: Pharmaceutical. CAS No. 17406-45-0. Pack Sizes: 20 mg. Product ID: NP0027. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Tomentin | Tomentin, a natural plant coumarin which is isolated from the barks of Jatropha curcas, exhibits anti-inflammatory activity. Tomentin also can inhibit papain-like protease. Uses: Anti-inflammatory. Group: Pharmaceutical. CAS No. 28449-62-9. Pack Sizes: 5 mg. Product ID: NP1173. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Toosendanin | Toosendanin is a natural diterpenoid compound found in the barks of Melia toosendan Sieb. et Zucc. Toosendanin shows hepatotoxicity and is also an effective insecticide for Ae. Group: Pharmaceutical. CAS No. 58812-37-6. Pack Sizes: 20 mg. Product ID: NP6990. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Topiramate Impurities | Topiramate Impurities are essential in the pharmaceutical industry for quality control and synthetic development of the antiepileptic drug Topiramate. These impurities offer insights into the drug's purity, stability, and efficacy, vital for treating epilepsy and migraine disorders efficiently and safely. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Topiroxostat | Topiroxostat is a novel and potent xanthine oxidoreductase (XOR) inhibitor. Uses: Enzyme inhibitors. Group: Pharmaceutical. CAS No. 577778-58-6. Pack Sizes: 50 mg. Product ID: B0084-463289. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Topiroxostat Impurities | Topiroxostat Impurities are essential in the pharmacological evaluation of Topiroxostat, a drug used to manage hyperuricemia in gout patients. These impurities help elucidate the drug's purity, safety, and efficacy by identifying potential toxicological effects and ensuring quality control during the drug's formulation and manufacturing processes. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
Would you like to list your products on UK Chemical Suppliers?
Our database is helping our users find suppliers everyday.